The Role of the Immune Response in Periodontal Diseases
Periodontal disease is known to be initiated by microbial plaque. The course of periodontal disease is affected by multiple factors such as microbial factors, genetic factors and environmental factors. The balance between these factors is important to determine the periodontal status and severity of the diseases. The host immunity is specific for each individual, resulting in the distinctive susceptibility of the disease in the population. Complex mechanisms of immunity could determine the progression or regression of periodontal disease. Understanding the role of immunity in perio-dontal disease could further lead to the proper management of the disease.
1. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. 4th ed. PA. W.B. Saunders Company; 2000: 2.
2. Oliver RC, Brown LJ, Löe H. Periodontal diseases in the United States population. J Periodontol 1998; 69: 269-278.
3. Lamster IB, Smith QT, Celenti RS, et al. Development of a risk profile for periodontal disease: microbial and host response factors. J Periodontol 1994; 65: 511-520.
4. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol 2005; 7: 3-7.
5. Michalowicz BS. Genetic and heritable risk factors in periodontal disease. J Periodontol 1994; 65: 479-488.
6. Sanders LA, Feldman RG, Voorhorst Ogink MM, et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 1995; 63: 73-81.
7. Attstrom R, Schroeder HE. Effect of experimental neutropenia on initial gingivitis in dogs. Scand J Dent Res 1979; 87: 7-23.
8. Hemmerle J, Frank RM. Bacterial invasion of periodontal tissues after experimental immunosuppression in rats. J Biol Buccale 1991; 19: 271-282.
9. Marshall RI. Gingival defensins. Linking the innate and adaptive immune response to plaque. Periodontol 2000 2004; 35: 14-20.
10. Darveau RP, Tanner A, Page RC. The microbial challenge in periodontitis. Periodontol 2000 1997; 14: 12-32.
11. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994; 5: 78-111.
12. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996; 1: 821-878.
13. Zambon JJ. Periodontal diseases: microbial factors. Ann Periodontol 1996; 1: 879-925.
14. Kinane DF, Lappin DF. Clinical, pathological and immunological aspects of periodontal disease. Acta Odontol Scand 2001; 59: 154- 160.
15. Socransky SS, Haffajee AD. The nature of periodontal diseases. Ann Periodontol 1997; 2: 3-10.
16. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
17. Kantarci A, OyaizuK, Van Dyke TE. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol 2003; 74: 66-75.
18. Kantarci A, Van Dyke TE. Neutrophilmediated host response to Porphyromonas gingivalis. J Int Acad Periodontol 2002; 4: 119-125.
19. Shapira L, Borinski R, Sela MN, et al. Superoxide formation and chemiluminescence of peripheral polymorphonuclear leukocytes in rapidly progressive periodontitis patients. J Clin Periodontol 1991; 18: 44-48.
20. Van Dyke TE, Zinney W, Winkel K, et al. Neutrophil function in localized juvenile periodontitis–phagocytosis, superoxide production and specific granule release. J Periodontol 1986; 57: 703-708.
21. Irwin CR, Myrillas TT. The role of IL-6 in the pathogenesis of periodontal disease. Oral Dis 1998; 4: 43-47.
22. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998; 9: 248-266.
23. Lloyd AR, Oppenheim JJ. Poly’s lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992; 13: 169-172.
24. Seymour GJ, Gemmell E, Reinhardt RA, et al. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodontal Res 1993; 28: 478- 486.
25. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997; 14: 33-53.
26. Schlegel Gomez R, Langer P, Pelka M, et al. Variational expression of functionally different macrophage markers (27E10, 25F9, RM3/1) in normal gingiva and inflammatory periodontal disease. J Clin Periodontol 1995; 22: 341-346.
27. Gemmell E, Seymour GJ. Modulation of immune responses to periodontal bacteria. Curr Opin Periodontol 1994; 94: 28-38.
28. Gemmell E, Seymour GJ. Cytokine profiles of cells extracted from humans with periodontal diseases. J Dent Res 1998; 77: 16-26.
29. Mooney J, Kinane DF. Humoral immune response to Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in adult peirodontitis and rapidly progressive periodontitis. Oral Microbiol Immunol 1994; 9: 321-326.
30. Lopatin DE, Blackburn E. Avidity and titer of immunoglobulin G subclasses to Porphyromonas gingivalis in adult periodontitis patients. Oral Microbiol Immunol 1992; 7: 332-337.
31. Whitney C, Ant J, Moncla B, et al. Serum immunoglobulin G antibody to Porphy-romonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution. Infect Immun 1992; 60: 2194- 2200.
32. MorinushiT, Lopatin DE, Van Poperin N, et al. The relationship between gingivitis and colonization by Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in children. J Periodontol 2000; 71: 403-409.
33. Polak B, Vance JB, Dyer JK, et al. IgG antibody subclass response to Porphyromonas gingivalis outer membrane antigens in gingivitis and adult periodontitis. J Periodontol 1995; 66: 363-368.
34. Wilton JM, Hurst TJ, Sterne JA. Elevated opsonic activity for Porphyromonas (Bacteroides) gingivalis in serum from patients with a history of destructive periodontal disease. A case: control study. J Clin Periodontol 1993; 20: 563-569.
35. Cutler CW, Arnold RR, Schenkein HA. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis. J Immunol 1993; 151: 7016-7029.
36. Underwood K, Sjostrom K, Darveau R, et al. Serum antibody opsonic activity against Actinobacillus actinomycetemcomitans in human periodontal diseases. J Infect Dis 1993; 168: 1436-1443.
37. Siveke JT, Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 1998; 160: 550-554.
38. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004; 35: 21-41.
39. Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 1993; 64: 432-444.
40. Page RC, Offenbacher S, Schroeder HE, et al. Advances in the pathogenesis of periodontitis: summary of developments, clinical implication and future directions. Periodontol 2000 1997; 14: 216-248.
41. Hennig BJ, Parkhill JM, Chapple IL, et al. Dinucleotide repeat polymorphism in the interleukin-10 gene promoter (IL-10.G) and genetic susceptibility to early-onset periodontal disease. Genes Immun 2000; 1: 402- 404.
42. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 24: 72-77.
43. Parkhill JM, Hennig BJ, Chapple IL, et al. Association of interleukin -1 gene polymorphisms with early-onset periodontitis. J Clin Periodontol 2000; 27: 682-689.
44. McDevitt MJ, Wang HY, Knobelman C, et al. Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontol 2000; 71: 156-163.
45. Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune hoemeostasis and tissue destruction in periodontal disease. Periodontol 2000 1997: 14: 112-143.
46. Pilon M, Williams-Miller C, Cox DS. Interleukin-2 levels in gingival crevicular fluid in periodontitis. J Dent Res 1991; 70: 550 (Abst2270).
47. Fujihashi K, Kino Y, YamamotoM, et al. Interleukin production by gingival mononuclear cells isolated from adult periodontitis patients. Dent Res 1991; 70: 550 (Abstr2269).
48. Taylor JJ, Preshaw PM, Donaldson PT. Cytokine gene polymorphisms and immunoregulation in periodontal disease. Periodontol 2000 2004; 35: 158-182.
49. Yamamoto M, Fujihashi K, Hiroi T, et al. Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokine in induction of mucosal inflammation. J Periodontal Res 1997; 32: 115-119.
50. Modlin RL, Nutman TB, Type 2 cytokines and negative immune regulation in human infections. Curr Opin Immunol 1993; 5: 511- 517.
51. Lindhe J, Liljenberg B, Listgarten M. Some microbiological and histopathological features of periodontal disease in man. J Periodontol 1980: 51: 264-269.
52. Mackler BF, Frostad KB, Robertson PB, et al. Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease. J Periodontal Res 1977; 12: 37-45.
53. Reinhardt RA, Bolton RW, McDonald TL, et al. In situ lymphocyte subpopulations from active versus stable periodontal sites. J Periodontol 1988; 59: 656-670.
54. Seymour GJ, Greenspan JS. The phenotypic characterization of lymphocyte subpopulations in established human periodontal disease. J Periodontal Res 1979; 14: 39-46.
55. Haffajee AD, Socransky SS, Smith C, et al. Microbial risk indicators for periodontal attachment loss. J Periodontal Res 1991; 26: 293-296.
56. Page PC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976; 33: 235- 249.
57. Robertson PB, Lantz PT, Marucha PT, et al. Collagenolytic activity associated with Bacteroides species and Actinobacillus actinomycetemcomitans. J Periodontal Res 1982; 17: 275-283.
58. Uitto V-J, Chang ECS, Chin Quee T. Initial characterization of neutral proteinases from oral spirochaetes. J Periodontal Res 1986; 21: 95-100.
59. Gazi MI, Cox SW, Clark DT, et al. Characterization of protease activities in Capnocytophago spp., Porphyromonas gingivalis, Prevotella spp., Treponema denticola and Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1997; 12: 240-248.
60. Suido H, Nakamura M, Mashimo PA, et al. Arylaminopeptidase activities of oral bacteria. J Dent Res 1986; 65: 1335-1340.
61. Uitto V-J, Grenier D, Chan ECS, et al. Isolation of a chymotrypsin-like enzyme from Treponema denticola. Infect Immun 1988; 56: 2717-2722.
62. Cox SW, Gazi MI, Clark DT, et al. Host tissue and Porphyromonas gingivalis dipeptidyl peptidase activities in gingival crevicular fluid. J Dent Res 1990; 72: 705.
63. Gazi MI, Cox SW, Clark DT, et al. Comparison of host tissue and bacterial dipeptidylpeptidases in human gingival crevicular fluid by analytical isoelectric focusing. Arch Oral Biol 1995; 40: 731-736.
64. Kuramitsu HK. Proteases of Porphyromonas gingivalis: what don’ t they do? Oral Microbiol Immunol 1998; 13: 263-270.
65. Darveau RP, Cunningham MD, Bailey T, et al. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun 1995; 63: 1311-1317.
66. Madianos PN, Papapanou PN, Sandros J. Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect Immun 1997; 65: 3983-3990.
67. Ashkenazi M, White RR, Dennison DK. Neutrophil modulation by Actinobacillus actinomycetemcomitans. I. Chemotaxis, surface receptor expression and F-actin polymerization. J Periodontal Res 1992; 27: 264- 273.
68. Ashkenazi M, White RR, Dennison DK. Neutrophil modulation by Actinobacillus actinomycetemcomitans. II. Phagocytosis and development of respiratory burst. J Periodontal Res 1992; 27: 457-465.
69. Mangan DF, Taichman NS, Lally ET, et al. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun 1991; 59: 3267- 3272.
70. Taichman NS, Dean RT, Sanderson CJ. Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans. Infect Immun 1980; 28: 258-268.
71. Taichman NS, Iwase M, Lally ET, et al. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells. J Immunol 1991; 147: 3587-3594